Download MendeleyStructural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.
Cole, D.K., van den Berg, H.A., Lloyd, A., Crowther, M.D., Beck, K., Ekeruche-Makinde, J., Miles, J.J., Bulek, A.M., Dolton, G., Schauenburg, A.J., Wall, A., Fuller, A., Clement, M., Laugel, B., Rizkallah, P.J., Wooldridge, L., Sewell, A.K.(2017) J Biol Chem 292: 802-813
- PubMed: 27903649
- DOI: https://doi.org/10.1074/jbc.M116.741603
- Primary Citation of Related Structures:
5MEN, 5MEO, 5MEP, 5MEQ, 5MER - PubMed Abstract:
T-cell cross-reactivity is essential for effective immune surveillance but has also been implicated as a pathway to autoimmunity. Previous studies have demonstrated that T-cell receptors (TCRs) that focus on a minimal motif within the peptide are able to facilitate a high level of T-cell cross-reactivity. However, the structural database shows that most TCRs exhibit less focused antigen binding involving contact with more peptide residues. To further explore the structural features that allow the clonally expressed TCR to functionally engage with multiple peptide-major histocompatibility complexes (pMHCs), we examined the ILA1 CD8 + T-cell clone that responds to a peptide sequence derived from human telomerase reverse transcriptase. The ILA1 TCR contacted its pMHC with a broad peptide binding footprint encompassing spatially distant peptide residues. Despite the lack of focused TCR-peptide binding, the ILA1 T-cell clone was still cross-reactive. Overall, the TCR-peptide contacts apparent in the structure correlated well with the level of degeneracy at different peptide positions. Thus, the ILA1 TCR was less tolerant of changes at peptide residues that were at, or adjacent to, key contact sites. This study provides new insights into the molecular mechanisms that control T-cell cross-reactivity with important implications for pathogen surveillance, autoimmunity, and transplant rejection.
Organizational Affiliation:
From the Division of Infection and Immunity and Systems Immunity Research Institute, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom, coledk@cf.ac.uk.
